
Keywords: GEP; gene expression profiling; PFS; progression free survival; DRP; drug response prediction; TT; Total therapy; IMWG; The International Myeloma Work Group; ASCT; autologous stem cell transplantation; MMSET-high; high expression levels of MMSET; MAF-high